REFERENCES
- Youlden DR, Cramb SM, Dunn NA, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237–248
- Benevento R, Santoriello A, Pellino G, et al. The effects of low-thrombin fibrin sealant on wound serous drainage, seroma formation and length of postoperative stay in patients undergoing axillary node dissection for breast cancer. A randomized controlled trial. Int J Surg. 2014;12:1210–1215.
- Agrawal A, Ayantunde AA, Cheung KL. Concepts of seroma formation and prevention in breast cancer surgery. ANZ J Surg. 2006;76:1088–1095.
- Sampathraju S, Rodrigues G. Seroma formation after mastectomy: pathogenesis and prevention. Indian J Surg Oncol. 2010;1:328–333.
- Yang Y, Gao E, Liu X, et al. Effectiveness of OK-432 (Sapylin) to reduce seroma formation after axillary lymphadenectomy for breast cancer. Anna Surg Oncol. 2013;20:1500–1504.
- Oba MS, Teramukai S, Ohashi Y, et al. The efficacy of adjuvant immunochemotherapy with OK-432 after curative resection of gastric cancer: an individual patient data meta-analysis of randomized controlled trials. Gastric cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2016;19(2);616–624.
- Yang Y, Chen Y, Qu J, et al. The use of OK-432 to prevent seroma in extended latissimus dorsi flap donor site after breast reconstruction. J Surg Res. 2015;193:492–496.
- Harris M, Chung F. Complications of general anesthesia. Clin Plast Surg. 2013;40:503–513.
- Xiang K, Cai H, Song Z. Comparison of analgesic effects of remifentanil and fentanyl NCA after pediatric cardiac surgery. J Invest Surg. 2014;27:214–218.
- Sun J, Yin J, Ning L, et al. Clinicopathological characteristics of breast cancers with axillary skip metastases. J Invest Surg. 2012;25:33–36.
- Nevola Teixeira LF, Sandrin F. The role of the physiotherapy in the plastic surgery patients after oncological breast surgery. Gland Surg. 2014;3:43–47.
- Srivastava V, Basu S, Shukla VK. Seroma formation after breast cancer surgery: what we have learned in the last two decades. J Breast Cancer. 2012;15:373–380.
- Petito EL, Esteves MT, Elias S, et al. The influence of the initiation of an exercise programme on seroma formation and dehiscence following breast cancer surgery. J Clin Nurs. 2014;23:3087–3094.
- Mazouni C, Mesnard C, Cloutier AS, et al. Quilting sutures reduces seroma in mastectomy. Clin Breast Cancer. 2015;15:289–293.
- Gilly FN, Francois Y, Sayag-Beaujard AC, et al. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur Surg Res. 1998;30:439–443.
- Carcoforo P, Soliani G, Maestroni U, et al. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial. J Am Coll Surg. 2003;196:365–369.
- Carcoforo P, Soliani G, Maestroni U, et al. Relationship between octreotide and breast surgery. Breast J. 2005;11:223.
- Schultz I, Barholm M, Grondal S. Delayed shoulder exercises in reducing seroma frequency after modified radical mastectomy: a prospective randomized study. Ann Surg Oncol. 1997;4:293–297.
- Flew TJ. Wound drainage following radical mastectomy: the effect of restriction of shoulder movement. Br J Surg. 1979;66:302–305.
- Hovden AO, Karlsen M, Jonsson R, et al. Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses. BMC Immunol. 2011;12:2.
- Ogita S, Tsuto T, Tokiwa K, et al. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg. 1987;74:690–691.
- Roh JL, Kim HS. Primary treatment of pediatric plunging ranula with nonsurgical sclerotherapy using OK-432 (Picibanil). Int J Pediatr Otorhinolaryngol 2008;72:1405–1410.
- Yoo JC, Ahn Y, Lim YS, et al. OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result. Otolaryngol Head Neck Surg. 2009;140:120–123.
- Choi YD, Cho SY, Cho KS, et al. Percutaneous treatment of renal cysts with OK-432 sclerosis. Yonsei Med J. 2007;48:270–273.
- Miwa T, Tatsutomi S, Tsukatani T, et al. OK-432 therapy for a cervical thoracic duct cyst. Otolaryngol Head Neck Surg. 2007;136:852–853.
- Kitsuki H, Katano M, Ikubo A, et al. Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-gamma in enhancement of surface expression of ICAM-1 on tumor cells in vivo. Clin Immunol Immunopathol. 1996;78:283–290.